This event is archived. Final snapshot from when the story concluded. View on Dashboard
Business securities fraud lawsuit

Boston Scientific Securities Fraud Lawsuit

Analysis based on 10 articles · First reported Feb 06, 2026 · Last updated Mar 11, 2026

Sentiment
-20
Attention
2
Articles
10
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard

The market was negatively impacted by Boston Scientific's disappointing financial results and subsequent stock price drop. The ongoing securities fraud lawsuit adds further uncertainty and negative sentiment towards Boston Scientific.

Medical devices Legal services

Boston Scientific reported disappointing fourth quarter and full year 2025 results, including lower-than-expected U.S. Electrophysiology sales and fiscal 2026 guidance. The company attributed this to slower market growth and increased competition, despite prior optimistic statements. Following this news, Boston Scientific's stock price fell by 17.6%. Consequently, the Law Offices of Howard G. Smith filed a securities fraud class action lawsuit against Boston Scientific, alleging that the company made materially false and misleading statements regarding its U.S. EP segment's growth trajectory and competitive landscape. Investors who purchased Boston Scientific securities during the Class Period (July 23, 2025, to February 3, 2026) are encouraged to participate in the lawsuit.

100 Law Offices of Howard G. Smith filed a securities fraud class action lawsuit Boston Scientific
95 Boston Scientific stock price fell by 17.6%
90 Boston Scientific reported disappointing Q4 and full-year 2025 results and issued weak 2026 guidance
stock
Boston Scientific is facing a securities fraud lawsuit due to allegedly misleading statements regarding its U.S. Electrophysiology segment's growth and competition. This led to a significant drop in its stock price, injuring investors.
Importance 100 Sentiment -70
priv
The Law Offices of Howard G. Smith is representing investors in a class action lawsuit against Boston Scientific, seeking to recover losses for those who purchased Boston Scientific securities during the Class Period.
Importance 80 Sentiment 50
exch
Boston Scientific's stock is traded on the New York Stock Exchange under the ticker BSX.
Importance 10 Sentiment 0
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.